Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

Nature Medicine

Volumn 3, Issue 4, 1997, Pages 402-408

  Klein, Karen A ^a   Reiter, Robert E ^a   Redula, James ^a   Moradi, Hamid ^a   Zhu, Xaio Lin ^b   Brothman, Arthur R ^b   Lamb, Dolores J ^c   Marcelli, Marco ^c   Belldegrun, Arie ^a   Witte, Owen N ^a   Sawyers, Charles L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CANCER TRANSPLANTATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGENS; ANIMALS; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 16944366096     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0497-402     Document Type: Article

References (13)

1. Ware, J.L. & Maygarden, S.J. Metastatic diversity in human prostatic carcinoma: Implications of growth factors and growth factor receptors for the metastatic phenotype. Pathol. Immunopathol. Res. 8, 231-249 (1989).
2. Pretlow, T.G., Delmoro, C.M., Dilley, G.G., Spadafora, C.G. & Pretlow, T.P. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res. 51, 3814-3817 (1991).
3. Pretlow, T.G. et al. Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst. 85, 394-398 (1993).
4. Luberoff, D.M., Cohen, M.B., Schultz, L.D. & Beamer, W.G. Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2 activated lymphocytes in scid mice. Prostate 1, 32-41 (1995).
5. Wainstein, M.A. et al. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 54, 6049-6052 (1994).
6. Liu, A.Y., Corey, E., Bladou, F., Lange, P.H. & Vessella, R.L. Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration. Intl. J. Cancer 65, 85-89 (1996).
7. van Weerden, W.M. et al. Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am. J. Pathol. 149, 1055-1062 (1996).
8. Wu, H.C. et al. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells. Intl. J. Cancer 57, 406-412 (1994).
9. Noel, A., Simon, N., Raus, J. & Foidart, J.M. Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochemical Pharmacology 43, 1263-1267 (1992).
10. Lim, D.J. et al. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 22, 109-118 (1993).
11. Pang, S. et al. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum. Gene Ther. 6, 1417-1426 (1995).
12. Horoszewicz, J.S. et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809-1818 (1983).
13. Wakasugi, H. et al. Frequent development of murine T-cell lymphomas with TcR alpha/beta+ cells in BALB/c nude mice. Jpn. J. Cancer Res. 86, 1086-1096 (1995).